PG-110 (ProGen)

N/A

Report date: 2025/07/02 10:19:22

Base Information

Drug NamePG-110 (ProGen)
Drug Alias NamePG-110 (ProGen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionActivin receptor type-2A inhibitorsActivin receptor type-2B inhibitorsAnti-Growth/differentiation factor 8
TargetsActivin receptor type-2AActivin receptor type-2BGrowth/differentiation factor 8
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProGen Co LtdKorea Drug Development Fund
China Registration ClassN/A

Develop Information

Active CompaniesKorea Drug Development FundProGen Co Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A